Literature DB >> 25158196

Rapid 1α,25(OH)₂D ₃ membrane-mediated activation of Ca²⁺/calmodulin-dependent protein kinase II in growth plate chondrocytes requires Pdia3, PLAA and caveolae.

Maryam Doroudi1, Barbara D Boyan, Zvi Schwartz.   

Abstract

1α,25-Dihydroxy vitamin D3 [1α,25(OH)2D3] regulates growth zone chondrocytes (GC) via classical steroid hormone receptor-mediated gene transcription and by initiating rapid membrane-mediated signaling pathways. 1α,25(OH)2D3 initiates its membrane effects via its specific membrane-associated receptor (Pdia3) in caveolae. 1α,25(OH)2D3 binding to Pdia3 leads to phospholipase-A2 (PLA2)-activating protein (PLAA) activation, stimulating PLA2, resulting in prostaglandin E2 (PGE2) release and protein kinase C activation. Recently, we reported that 1α,25(OH)2D3 rapidly activates Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) in GC cells. However, the roles of Pdia3, PLAA and caveolae in 1α,25(OH)2D3-dependent rapid activation of CaMKII are not clear. The aim of the present study was to evaluate the roles of Pdia3, PLAA and caveolae in 1α,25(OH)2D3 membrane-stimulated CaMKII activation. Pre-treating chondrocytes from the growth zone of the rat costochondral cartilage with antibodies against PLAA or Pdia3 blocked activation of CaMKII by 1α,25(OH)2D3. PLAA peptide rapidly activated CaMKII in GC cells. Caveolae disruption abolished CaMKII activation in response to 1α,25(OH)2D3 or PLAA peptide treatment. Immunoprecipitation studies showed increased CaM binding to PLAA in response to 1α,25(OH)2D3. The results indicated that Pdia3, PLAA and caveolae are required for rapid 1α,25(OH)2D3 membrane-mediated activation of CaMKII. 1α,25(OH)2D3 signaling via Pdia3 receptor triggered the interaction between PLAA and CaM suggesting that CaM may play a major role linking PLAA to CaMKII in membrane-mediated actions of 1α,25(OH)2D3.

Entities:  

Keywords:  Caveolae; non-genomic actions; phospholipase A2 activating protein; protein disulfide isomerase A3; rapid actions; secosteroid hormone

Mesh:

Substances:

Year:  2014        PMID: 25158196     DOI: 10.3109/03008207.2014.923882

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  5 in total

1.  Phospholipase A2-activating protein is associated with a novel form of leukoencephalopathy.

Authors:  Tzipora C Falik Zaccai; David Savitzki; Yifat Zivony-Elboum; Thierry Vilboux; Eric C Fitts; Yishay Shoval; Limor Kalfon; Nadra Samra; Zohar Keren; Bella Gross; Natalia Chasnyk; Rachel Straussberg; James C Mullikin; Jamie K Teer; Dan Geiger; Daniel Kornitzer; Ora Bitterman-Deutsch; Abraham O Samson; Maki Wakamiya; Johnny W Peterson; Michelle L Kirtley; Iryna V Pinchuk; Wallace B Baze; William A Gahl; Robert Kleta; Yair Anikster; Ashok K Chopra
Journal:  Brain       Date:  2016-12-21       Impact factor: 13.501

Review 2.  Do Interactions of Vitamin D3 and BMP Signaling Hold Implications in the Pathogenesis of Fibrodysplasia Ossificans Progressiva?

Authors:  Jessica L Pierce; Daniel S Perrien
Journal:  Curr Osteoporos Rep       Date:  2021-04-14       Impact factor: 5.163

3.  Calcitriol, the Bioactive Metabolite of Vitamin D, Increases Ventricular K+ Currents in Isolated Mouse Cardiomyocytes.

Authors:  María Tamayo; Laura Martin-Nunes; Almudena Val-Blasco; Maria J Piedras; María J Larriba; Nieves Gómez-Hurtado; María Fernández-Velasco; Carmen Delgado
Journal:  Front Physiol       Date:  2018-08-24       Impact factor: 4.566

4.  Extracorporeal Shockwave Therapy Enhances Expression of Pdia-3 Which Is a Key Factor of the 1α,25-Dihydroxyvitamin D 3 Rapid Membrane Signaling Pathway in Treatment of Early Osteoarthritis of the Knee.

Authors:  Shan-Ling Hsu; Jai-Hong Cheng; Ching-Jen Wang; Jih-Yang Ko; Chih-Hsiang Hsu
Journal:  Int J Med Sci       Date:  2017-09-19       Impact factor: 3.738

5.  Altered spontaneous calcium signaling of in situ chondrocytes in human osteoarthritic cartilage.

Authors:  Xiaoyuan Gong; Wenbin Xie; Bin Wang; Lingchuan Gu; Fuyou Wang; Xiang Ren; Cheng Chen; Liu Yang
Journal:  Sci Rep       Date:  2017-12-06       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.